Stay updated on NICO Study: Oral Cancer Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the NICO Study: Oral Cancer Immunotherapy Clinical Trial page.

Latest updates to the NICO Study: Oral Cancer Immunotherapy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe clinical trial record for NICO (NCT03721757) is available, describing nivolumab alongside surgery and radiation or chemoradiation for oral cavity cancer. It also includes participant eligibility, study outcomes, investigators, and the trial’s completed status.SummaryDifference56%

- Check15 days agoChange DetectedThe site revision label changes from v3.7.2 to v3.8.0 while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check29 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2; the study page continues to show a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check50 days agoChange DetectedA 403 Forbidden error page now appears when attempting to view the study record, indicating restricted access. The page displays the standard 403 message and a Home link, replacing the expected study details.SummaryDifference0.5%

Stay in the know with updates to NICO Study: Oral Cancer Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NICO Study: Oral Cancer Immunotherapy Clinical Trial page.